The appointment takes fifteen minutes. Do you smoke, do you get migraines, what is your blood pressure, does anyone in your family have a history of blood clots. Then the prescription is written, and for most people that is the right outcome.
The question that would catch most of the actual risk is not on the list. It is a test for a single gene, and the reason it is not asked is not negligence. It is arithmetic, and the arithmetic has changed.
What Factor V Leiden is
Factor V is one of the proteins that makes your blood clot. In most people it switches off when the job is done. Factor V Leiden is a one-letter change that makes the protein resist its off switch, so clots form a little more readily and dissolve a little more slowly. About one in twenty people of European descent carry it, almost all without knowing, and among white patients who turn up with a deep vein clot, between one in ten and one in three turn out to be carriers.
On its own it is a modest risk. Most carriers go their whole lives without a clot. The gene matters when something else pushes in the same direction, and the most common thing that does is estrogen.
What estrogen does to it
Combined birth control, the pill, patch or ring that contains estrogen, raises clot risk in everyone. For a young woman not on hormones the chance of a clot is somewhere around 1 to 5 in 10,000 per year; on the pill it runs closer to 8 to 15. Small numbers, and for most people an acceptable trade.
For a carrier the two risks do not add. They multiply. Estimates of the combined effect range from 10 to 15 times baseline in later studies to over 30 times in the original one, and in a cohort of carriers followed on the pill the clot rate came out at roughly 1 in 200 per year, with the first two years the most dangerous. The World Health Organization classes combined hormonal contraception as an unacceptable health risk for anyone with a known clotting mutation.
Why nobody checks
The same WHO guidance that calls the combination unacceptable also advises against testing everyone for the gene before prescribing. The reasoning is honest: the test costs money, nineteen in twenty women will be negative, and the absolute risk even for carriers is low enough that screening every patient does not pay for itself.
So the family history question stands in for the test, and it is a poor substitute. Most carriers have no family history they know of. Those who do already tend to avoid the pill, which means the question mostly catches people who did not need catching. Everyone else is prescribed on the assumption they are not a carrier, and the assumption is checked the day a clot arrives.
What your DNA adds
Every argument against screening is an argument about cost per person. A genome you already have costs nothing more to read, and the arithmetic that has kept this test off the checklist for thirty years does not apply to you.
If you carry the variant, you know it before the appointment rather than after the clot, and the decision is easy, because it was never a choice between contraception and no contraception. The progestin-only pill, the hormonal IUD, the copper IUD and the implant do not carry the estrogen risk; the hormonal IUD in particular shows no increase in clots at all. Same protection, different method, one conversation.
If you do not carry it, you know that too, and your risk on the pill is the ordinary low one that the guidelines were written for. That is worth having in writing when you are being told to worry.
And the gene does not stop mattering when you stop taking the pill. The same variant raises clot risk in pregnancy, after surgery, on long flights and on hormone therapy at menopause. One result covers several decades of decisions, and a whole genome also sees the other clotting variants that a single-gene test would miss.
What to do with it
Your prescription. If you carry the variant and are being offered a combined pill, patch or ring, bring the result and ask about a progestin-only or non-hormonal method. Do not stop a method you are already on without the next one arranged.
Your first two years. If you are a carrier already on estrogen, the risk is highest early. That is a reason to talk to your prescriber this month, not a reason to panic.
Your family. Each of your parents, siblings and children has a coin-flip chance of carrying it if you do. Daughters approaching the age of their first prescription are the people most worth telling.
Your future self. Pregnancy, surgery, long-haul travel and menopause each raise the same question again. You answered it once.
This is information rather than a diagnosis. Decisions about contraception belong with your prescriber, and sudden swelling or pain in one leg, chest pain or breathlessness are reasons to seek emergency care regardless of your genotype.
The same reading, everywhere else
The gene behind this post sits a few chapters from the ones that decide how you react to anesthesia, whether your cholesterol is diet or inheritance, and how your body handles the medications you will be prescribed for the rest of your life. All of it is in one file, and you read it once.
Lifecode reads all 6.4 billion letters and re-reads them as the science improves. That is why we built it.
Read your own genome.
Order your genome